Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
European Journal of Obstetrics & Gynecology and Reproductive Biology Feb 22, 2018
Braga A, et al. - Whether or not a human chorionic gonadotropin (hCG) level ≥ 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole (CHM) is an appropriate indicator for initiating chemotherapy for the treatment of gestational trophoblastic neoplasia (GTN) was determined. A hCG level ≥ 20,000 IU/L four weeks after uterine evacuation for CHM was very predictive of post-molar GTN; however, a delay in treatment until the hCG level plateaued or increased did not affect outcomes, with no uterine perforations or treatment failures.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries